Biotech

All Articles

Basilea ratings $268M BARDA financing for antifungals, antibiotics

.Basilea Pharmaceutica's work creating brand-new antifungals has gotten a notable increase coming fr...

Capricor offers Europe civil liberties to late-stage DMD treatment for $35M

.Having presently gathered up the united state legal rights to Capricor Therapies' late-stage Duchen...

FDA scraps adcomm for Applied's uncommon illness medicine

.After pushing back the decision meeting for Applied Rehabs' metabolic ailment medication govorestat...

Novo inks $600M NanoVation bargain to analyze hereditary medications ex-liver

.Novo Nordisk is proceeding its push into genetic medicines, agreeing to pay NanoVation Therapies ar...

Innovent links cytokine to intestines cancer responses

.Innovent Biologics has helped make the case that its checkpoint inhibitor-cytokine fusion protein p...

Merck, Daiichi ADC hits target in phase 3 lung cancer cells research study

.A phase 3 test of Daiichi Sankyo as well as Merck &amp Co.'s HER3-directed antibody-drug conjugate ...

Rakovina deepens AI concentrate along with collab to select cancer cells targets

.5 months after Rakovina Rehabs rotated toward artificial intelligence, the cancer-focused biotech h...

Ascendis' dwarfism medication favorites in stage 3, intimidates BioMarin

.Ascendis Pharma has actually emerged as a potential hazard to BioMarin's Voxzogo, reporting period ...

Despite ph. 3 overlook, Alkeus finds pathway in advance for eye illness asset

.Though Alkeus Pharmaceuticals' oral eye disease asset neglected to considerably minimize geographic...

Kairos goes social along with $6M IPO to fund trials of cancer cells medicine

.Along with a triad of biotechs reaching the Nasdaq on Friday, it was quick and easy to skip a small...